CBIO Q4 2019 Earnings — Crescent Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

CBIOCrescent Biopharma, Inc.

$337M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$228,312

Operating Income

-$15M

Net Income

-$15M

EPS (Diluted)

$-0.34

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$168M

Total Liabilities

$14M

Stockholders' Equity

$154M

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$228,312	-$68,329	-234.1%
Operating Income	-$15M	-$15M	-2.5%
Net Income	-$15M	-$14M	-5.9%